Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Thrombosis and Haemostasis

• Publication date

  2012-09-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1160/TH12-04-0232PMID 23014861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel roles of cAMP/cGMP‐dependent signaling in platelets

  2012cited by this paper
• Anti-platelet therapy: phosphodiesterase inhibitors.

  2011cited by this paper
• Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.

  2011cited by this paper
• Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice.

  2011cited by this paper
• Fluo‐cAMP is transported by multidrug resistance‐associated protein isoform 4 in rat choroid plexus

  2010cited by this paper
• cGMP and cGMP-dependent protein kinase in platelets and blood cells.

  2009cited by this paper
• Cellular efflux of cAMP and cGMP - a question about selectivity.

  2009cited by this paper
• ATP-Dependent Transport of Leukotrienes B4 and C4 by the Multidrug Resistance Protein ABCC4 (MRP4)

  2008cited by this paper
• Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules.

  2008cited by this paper
• Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation.

  2008cited by this paper
• Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications.

  2007cited by this paper
• Transport of a fluorescent cAMP analog in teleost proximal tubules.

  2007cited by this paper
• The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage.

  2004cited by this paper
• MRP8, ATP-binding Cassette C11 (ABCC11), Is a Cyclic Nucleotide Efflux Pump and a Resistance Factor for Fluoropyrimidines 2′,3′-Dideoxycytidine and 9′-(2′-Phosphonylmethoxyethyl)adenine*

  2003cited by this paper
• Characterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells*

  2003cited by this paper
• The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP.

  2002cited by this paper
• Taming platelets with cyclic nucleotides.

  2001cited by this paper
• Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine.

  2001cited by this paper
• The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides*

  2000cited by this paper
• An improved method for the isolation of dense storage granules from human platelets

  1978cited by this paper
• Energy metabolism of blood platelets. I. Isolation and properties of platelet mitochondria.

  1972influential reference

• Targeting MRP4 in drug resistance and aspirin treatment failure: implications for precision medicine.

  2026cites this paper
• Effects of cilostazol for in-stent restenosis after carotid artery stenting: a meta-analysis

  2025cites this paper
• Enhanced platelet sensitization is accompanied by increased expression of the transporter MRP4 and elevated plasma S1P levels in mild COVID-19 convalescents

  2024cites this paper
• Pseudomonas aeruginosa ExoY infection of pulmonary microvascular endothelial cells releases cyclic nucleotides into the extracellular compartment.

  2024cites this paper
• The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis

  2024cites this paper
• The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets

  2022influential citation
• Real world data from a multi-centre study on the effects of cilostazol on pain symptoms and walking distance in patients with peripheral arterial disease

  2022cites this paper
• Role of Membrane Lipid Rafts in MRP4 (ABCC4) Dependent Regulation of the cAMP Pathway in Blood Platelets

  2021cites this paper
• Multidrug resistance proteins preferentially regulate natriuretic peptide‐driven cGMP signalling in the heart and vasculature

  2021cites this paper
• The Provocative Roles of Platelets in Liver Disease and Cancer

  2021cites this paper
• Impact of Calcium Channel Blockers on Aspirin Reactivity in Patients with Coronary Artery Disease

  2021cites this paper
• Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance.

  2021cites this paper
• Cilostazol: a Review of Basic Mechanisms and Clinical Uses

  2021cites this paper
• Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism.

  2020cites this paper
• Cilostazol reduces cerebrovascular risk through the inhibition of multi-drug resistance protein 4/ATP binding cassette subfamily C member 4

  2020cites this paper
• MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation

  2020cites this paper
• MRP4/ABCC4 As a New Therapeutic Target: Meta-Analysis to Determine cAMP Binding Sites as a Tool for Drug Design.

  2019cites this paper
• Activation of soluble guanylyl cyclase with inhibition of multidrug resistance protein inhibitor‐4 (MRP4) as a new antiplatelet therapy

  2018cites this paper
• Platelet Transcriptome Profiling in HIV and ATP-Binding Cassette Subfamily C Member 4 (ABCC4) as a Mediator of Platelet Activity

  2018cites this paper
• Inhibition of Multidrug Resistance Proteins by MK 571 Enhances Bladder, Prostate, and Urethra Relaxation through cAMP or cGMP Accumulation

  2018cites this paper
• Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity

  2018cites this paper
• Release of Platelet-Derived Sphingosine-1-Phosphate Involves Multidrug Resistance Protein 4 (MRP4/ABCC4) and Is Inhibited by Statins

  2018cites this paper
• Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans

  2017cites this paper
• cGMP Signaling in Platelets

  2017cites this paper
• Targeting multidrug resistance proteins and C-type natriuretic peptide to optimise cyclic GMP signalling in cardiovascular disease

  2016cites this paper
• MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease.

  2016cites this paper
• Several adaptor proteins promote intracellular localisation of the transporter MRP4/ABCC4 in platelets and haematopoietic cells

  2016cites this paper
• Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment

  2016cites this paper
• Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets.

  2016cites this paper
• The Pharmacological and Physiological Role of Multidrug-Resistant Protein 4

  2015influential citation
• Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice.

  2015cites this paper
• Impaired platelet activation and cAMP homeostasis in MRP 4-deficient mice Short title : MRP 4 controls platelet cAMP homeostasis

  2015cites this paper
• Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets

  2014cites this paper
• Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo.

  2014cites this paper
• Analysis of Substrate Specificity and Kinetics of Cyclic Nucleotide Phosphodiesterases with N’-Methylanthraniloyl-Substituted Purine and Pyrimidine 3′,5′-Cyclic Nucleotides by Fluorescence Spectrometry

  2013cites this paper
• cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: Development of a hypothesis based on studies with soluble guanylyl cyclase α1β1

  2013cites this paper